• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Molecules . The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients

tetano

Editor, Senior Moderator
Molecules


. 2020 Dec 4;25(23):E5725.
doi: 10.3390/molecules25235725.
The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients


Alessandro G Fois[SUP] 1 2 [/SUP], Panagiotis Paliogiannis[SUP] 1 [/SUP], Valentina Scano[SUP] 1 [/SUP], Stefania Cau[SUP] 1 [/SUP], Sergio Babudieri[SUP] 1 [/SUP], Roberto Perra[SUP] 3 [/SUP], Giulia Ruzzittu[SUP] 4 [/SUP], Elisabetta Zinellu[SUP] 2 [/SUP], Pietro Pirina[SUP] 1 2 [/SUP], Ciriaco Carru[SUP] 5 [/SUP], Luigi B Arru[SUP] 6 [/SUP], Alessandro Fancellu[SUP] 1 [/SUP], Michele Mondoni[SUP] 7 [/SUP], Arduino A Mangoni[SUP] 8 [/SUP], Angelo Zinellu[SUP] 5 [/SUP]



Affiliations

Abstract

Background: The rapid onset of a systemic pro-inflammatory state followed by acute respiratory distress syndrome is the leading cause of mortality in patients with COVID-19. We performed a retrospective observational study to explore the capacity of different complete blood cell count (CBC)-derived inflammation indexes to predict in-hospital mortality in this group.
Methods: The neutrophil to lymphocyte ratio (NLR), derived NLR (dNLR), platelet to lymphocyte ratio (PLR), mean platelet volume to platelet ratio (MPR), neutrophil to lymphocyte ? platelet ratio (NLPR), monocyte to lymphocyte ratio (MLR), systemic inflammation response index (SIRI), systemic inflammation index (SII), and the aggregate index of systemic inflammation (AISI) were calculated on hospital admission in 119 patients with laboratory confirmed COVID-19.
Results: Non-survivors had significantly higher AISI, dNLR, NLPR, NLR, SII, and SIRI values when compared to survivors. Similarly, Kaplan-Meier survival curves showed significantly lower survival in patients with higher AISI, dNLR, MLR, NLPR, NLR, SII, and SIRI. However, after adjusting for confounders, only the SII remained significantly associated with survival (HR = 1.0001; 95% CI, 1.0000-1.0001, p = 0.029) in multivariate Cox regression analysis.
Conclusions: The SII on admission independently predicts in-hospital mortality in COVID-19 patients and may assist with early risk stratification in this group.

Keywords: CBC; COVID-19; SII; coronavirus; inflammation.
 
Back
Top Bottom